Novo Nordisk Pharmatech has entered into an agreement with Helm de México, which will be responsible for the distribution of Novo's Quats (synthetic molecules) in Mexico.
"We are very excited to announce the new distribution agreement between Helm de México and Novo Nordisk Pharmatech. We believe it is a mutually beneficial agreement. On the one hand, Novo Nordisk Pharmatech will gain access to Helm's extensive network of customers in the pharmaceutical/cosmetics industry along with the distribution infrastructure HELM has built in the 55 years we have been present in the Mexican market," Boy Ehlers, Managing Director of Helm de México, says in a Novo Nordisk Pharmatech press release, adding:
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Carb-X secures USD 370m in fight against antibiotic resistance
International antibiotic alliance Carb-X has received commitments of up to USD 370m to accelerate the development of new antibiotics to combat a future shortage. The news is welcomed by several players on the AMR field.
Former Ambu CEO's equity investments end in USD 2m losses
Juan Jose Gonzalez, who was the CEO of medtech firm Ambu until very recently, has lost just over DKK 16m (USD 2.3m) before taxes on his share purchases.
Jesper Høiland retires as chief commercial officer of Ascendis Pharma
Former executive vice president of Novo Nordisk, US, Jesper Høiland has decided to step down from his role as global chief commercial officer at Ascendis Pharma.
ALK finds replacement for long-time North America lead
Jorge Alderete, ALK’s president in North America, is leaving the firm after 23 years. He will be replaced by Hans Lindeberg, ALK’s current head of the Nordic region.
Monkeypox vaccine attracts interest for Bavarian as virus spreads
Bavarian, which signed a supply contract with an unnamed European country last week, reports it is in dialog with several countries, some yet to be affected, concerning the firm’s monkeypox vaccine.
Laboratory technician for process development and clinical manufacturing 
Strategic Procurement Manager, Direct Spend (Category Manager) 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Director Global Engineering 
Consultant Manager 
Clinical Trial Administrator 
Production Director 
Nordic Medical Affairs Manager 
Project Manager & Scrum Master 
Analytical Coordinator for Analytical Development 
Client Talent Acquisition Specialist 
Account Manager 
Key Account Manager, Europe and Asia 
Clinical Trial Manager 
System Sales Development Consultant - Investment Projects, Merck Millipore